Research programme: Fragile X mental retardation protein inhibitors - Opna Bio
Alternative Names: OPN-FMRPLatest Information Update: 28 Nov 2022
Price :
$50 *
At a glance
- Originator Opna Bio
- Class Antineoplastics; Small molecules
- Mechanism of Action Fragile X mental retardation protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer